Spinal muscular atrophy: Where are we now? Current challenges and high hopes

Department of Gene Expression, Faculty of Biology, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University Poznań, Poznań, Poland

Katarzyna Morańska

Section of Regenerative Medicine and Cancer Research, Natural Sciences Society, Adam Mickiewicz University Poznań, Poznań, Poland

Alina Pienkowska Cancer Prevention and Epidemiology Center Inc., Poznań, Poland

Arkadiusz Kajdasz

Laboratory of Human Molecular Genetics, Faculty of Biology, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University Poznań, Poznań, Poland

Department of RNA Metabolism, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/ahem-2022-0030 | Journal eISSN: 1732-2693

Journal RSS Feed

Language: English

Page range: 407 - 419

Submitted on: Sep 19, 2021

Accepted on: Feb 7, 2022

Published on: Sep 12, 2022

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

spinal muscular atrophy,

AAV9,

Related subjects:

Microbiology and virology,

Medicine,

Basic medical science,

Immunology

© 2022 Marta Przymuszała, Maria Gwit, Jadwiga Waśko, Katarzyna Morańska, Arkadiusz Kajdasz, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 76 (2022): Issue 1 (January 2022)